Obtaining the prestigious PMDA certification in Japan.
After more than two years of intense work, we are proud to announce the obtaining of the prestigious authorization to sell for EchoS device in Japan issued by the PMDA Japan: Pharmaceuticals and Medical Devices Agency of Japan.
The important milestone is a further international recognition for Echolight obtained through a scrupulous work with the Japanese agency and the commercial partner Toyo Medic, a consolidated reality in the distribution of innovative medical devices that has signed an important exclusive sales agreement in the Japanese territory for the Echolight range of products.
In Japan, the issue of bone health is so crucial that the Japanese Ministry of Health, Labor and Welfare has undertaken a survey to quantify the costs related to deficiencies in bone density and structure, as well as the costs related to fractures in the older population. age 65 and it has been estimated that total costs have been nearly 944 billion Japanese yen (8 billion US dollars) and are increasing rapidly.
With the introduction of R.E.M.S. Japan is at the forefront in the diagnosis of osteoporosis, demonstrating its foresight by adopting a new concept of bone health based on prevention, early diagnosis and monitoring throughout the whole life aimed at reducing the risk of fragility fracture with direct benefits towards patients as well as the sustainability of their healthcare system.
In fact, the revolutionary EchoS device, for bone micro-architecture assessment of the lumbar vertebrae and the femoral neck, based on the proprietary and patented R.E.M.S. (Radiofrequency Echographic Multi Spectrometry), being radiation-free, fast, portable and accurate, it significantly increases the accessibility to the test for the entire Japanese population, favoring prevention and early diagnosis.
The expansion of Echolight and the adoption of R.E.M.S. by an ever-growing number of countries, now numbering over 40 around the world.
For more information:
REMS & DXA
REMS assessments: clinical settings REMS technology is recognized as useful tool in the management of osteoporosis and fracture prevention. Its portability and lack of ionizing radiation means it can be used in previously underserved populations, including pregnant...
REMS in Poland
POLAND: REMS IN THE RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS The 2026 recommendations for the Diagnosis and treatment of Osteoporosis in Poland have been now published in the scientific journal Rheumatology (2026 edition) “Diagnosis and...
REMS technology
REMS: capable of providing information that goes beyond anthropometric modelling alone “The manuscript entitled “Methodological clarification and analysis of demographic and anthropometric determinants in the calculation of REMS bone mineral density”, authored by...